Wall Street slips after rejection of Brexit timetable
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Mizuho Securities Reiterates Buy Rating on Facebook (FB) Following Investor Call
October 23, 2019 7:24 AM EDTMizuho Securities analyst James Lee reiterated a Buy rating and $247.00 price target on Facebook (NASDAQ: FB) following an investor call with a leading ad agency on FBs 3Q19 spending trends. The agencys SSS shows FB spending increased 32% YoY vs 37% 2Q19 due to agency-specific... More
Hasbro (HAS) PT Lowered to $90 at BMO Capital
October 23, 2019 6:52 AM EDTBMO Capital analyst Gerrick Johnson lowered the price target on Hasbro (NASDAQ: HAS) to $90.00 (from $105.00) while maintaining a Market Perform rating.
... MoreBiogen (BIIB) PT Raised to $305 at Canaccord Genuity
October 23, 2019 5:14 AM EDTCanaccord Genuity analyst Sumant Kulkarni raised the price target on Biogen (NASDAQ: BIIB) to $305.00 (from $285.00) while maintaining a Hold rating.
... MoreBiogen (BIIB) PT Raised to $297 at BMO Capital
October 23, 2019 4:44 AM EDTBMO Capital analyst George Farmer raised the price target on Biogen (NASDAQ: BIIB) to $297.00 (from $250.00) while maintaining a Market Perform rating.
The analyst comments "After a failed futility analysis reported last March, new results from the Phase 3 trials, EMERGE and ENGAGE, now support... More
Biogen (BIIB) PT Raised to $310 at Jefferies
October 22, 2019 1:45 PM EDTJefferies analyst Michael Yee raised the price target on Biogen (NASDAQ: BIIB) to $310.00 (from $255.00) while maintaining a Hold rating.
stock pricing in renewed hopes againasks if M&A could be next... MoreHasbro (HAS) Plunges Nearly 17% on Miss
October 22, 2019 9:35 AM EDTHasbro (NASDAQ: HAS) sinks 16.5% following its earnings miss.
... More


